Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by Stlouis28on Jul 31, 2019 7:37pm
204 Views
Post# 29981814

RE:RE:RE:RE:RE:RE:RE:GENE is making sales.

RE:RE:RE:RE:RE:RE:RE:GENE is making sales.
GENE has been re-stocking the OCS as well as retailers. You can find this information quite easily if you look online. Since you havent been following, heres a breif summary if whats happened in the past few months: GENE board completely changed. Former individuals responsable for the decisions in the past few years were given the boot. Trevor Dixon stepped in as CEO Expenses went from 16m per quarter to 4m per quarter Acreage pharms is growing 200kg per month of flower currently Phase 3 at acreage pharms will triple their current capacity AB Labs submitted readiness package to Health Canada for an 40000 sq ft facility which GENE owns 50% of Its also important to note that the CEO owns about 10 million shares personally
<< Previous
Bullboard Posts
Next >>